Table 1.
L. lactis strain | Expression system | Target pathogen | Heterologous protein | Immune response | Experimental model | Reference |
---|---|---|---|---|---|---|
L. lactis NZ3900 | NICE: pNZ8149-SLS-F5 and pNZ8149-SLS-F5-OmpH plasmids |
Enterotoxigenic Escherichia coli | SLS-F5-OmpH | Mucosal IgA and serum IgG and cellular immune response | BALB/c mice | 29 |
L. lactis MG1363 | Constitutive lactococcal promoter P23:30 pLZ12Km2P23:PilM1 (PilM1) and PilM1 strains containing introduced peptides plasmids |
Staphylococcus aureus | D3(22–33) | Mucosal and serum IgG and IgA | BALB/c mice | 31 |
L. lactis MG1363 | pH-inducible expression system: pAMJ and pAMJ- rOmp16-IL2 plasmids |
Brucella melitensis | Omp16-Human IL-2 | Serum IgG | BALB/c mice | 32 |
L. lactis MG1363 | pH-inducible expression system: pAMJ2008-CagL | Helicobacter pylori | CagL | Serum IgG, IgA and fecal IgA | BALB/c mice | 33 |
L. lactis FnBPA+: | pValac vector for DNA delivery | Mycobacterium tuberculosis | ESAT-6 and Ag85A | Colonic tissue IgA and cellular immune response | BALB/c mice | 34 |
L. lactis NZ900 | NICE: NZ8123-HPV16-optiE7 plasmid | Human Papillomavirus Type 16 | HPV-16 E7 oncogene | Serum IgG and vaginal IgA | Human | 35 |
L. lactis NZ9000 | NICE: pNZ8124::sip plasmid | Group B Streptococcus | SIP | Systemic and mucosal IgG and IgA and cellular immune response | C57BL/6 mice | 36 |
L. lactis MG1363 | Constitutive lactococcal promoter P32:30 pMG36e-VP1 plasmid | Enterovirus 71 | VP1 | Serum IgG and fecal IgA | BALB/c mice | 37 |
L. lactis NZ9000 | NICE: pNZ8150-pgsA-HAsd plasmid | H5N1, H3N2 and H1N1Influenza A viruses | HAsd | Serum IgG and mucosal IgA | BALB/c mice | 38 |
L. lactis MG1363 | Constitutive lactococcal promoter P32:30 pMG36e-TSOL18 and pMG36e-SP-TSOL18 plasmids | Taenia Solium | SP-TSOL18 | Serum IgG and mucosal IgA and cellular immune response | Kunming mice | 39 |
L. lactis MG1363 | pH-inducible expression system: pSS1 plasmid | Plasmodium falciparum | PfCSP4/38 | Serum IgG | CD1 mice | 40 |
L. lactis NZ9000 | NICE: pNZ8121- Ppsp15-egfp and pNZ8121-egfp plasmids |
Leishmania major | PpSP15 | Th1 type immune response | BALB/c mice | 41 |
L. lactis NZ3900 | NICE: pNZ8149-SECF1S1 plasmid | Bordetella pertussis | F1S1 | Serum IgG and mucosal IgA | BALB/c mice | 42 |
L. lactis IL1403 | Constitutive lactococcal promoter Ptuf:43 pILPtuf.nCoV.h plasmid | SARS-CoV-2 virus | RBD S1 | Serum IgG and fecal IgA | BALB/c mice | 44 |
L. lactis NZ9000 | NICE: pGEM-VP6 plasmid | Rotaviruses | VP6 | Serum IgG and IgA | BALB/c mice | 45 |